Get started
Author

DS Boyer

Observed names: D S Boyer, David Boyer
ORCID: 0000-0001-9219-1614
Observed ORCID: 0000-0001-9219-1614
OpenAlex ID: A5014532361
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study
2026 · Ashish Sharma, Arshad M. Khanani, et al. · Eye · 1
Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study
2026 · Jae Ryong Song, Jehwi Jeon, et al. · Scientific Reports
PDF
Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study
2026 · Ashish Sharma, Ahmed Abdelshafy Tabl, et al. · Eye
Fundus Fluorescein Angiography (FA) Complements OCT in Detecting Active Leakage in Patients With Exudative AMD
2010 · Homayoun Tabandeh, N. A. Chaudhry, et al. · Investigative Ophthalmology & Visual Science
Ocular Coherence Tomography (OCT) In Best's Disease: Demonstration of a Sub-Retinal Pigment Epithelial (RPE) Translucent Space
2002 · DS Boyer, EL Thomas, et al. · Investigative Ophthalmology & Visual Science
Acute and Chronic Endophthalmitis Caused by Alcaligenes Xylosoxidans: Hisopathologic findings
2002 · W B Thomas, E. Louise Thomas, et al. · Investigative Ophthalmology & Visual Science
Pneumatic Cyclocryopexy for Closure of Traumatic Cyclodialysis Clefts
2002 · RP Gallemore, AB Wolf, et al. · Investigative Ophthalmology & Visual Science
Pseudo-RPE Detachment Following Retinal Detachment Repair: Clinical and OCT Characteristics of Three Patients
2002 · TG Chu, DS Boyer, et al. · Investigative Ophthalmology & Visual Science
Save your sight. Eye disease and HIV.
2001 · R P Gallemore, D S Boyer · PubMed
Works count: 9
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type